Education
About Us
Working with TipRanks
Follow Us
InfuSystem Holdings, Inc. (INFU)
:INFU
INFU Stock Chart & Stats
$9.60
-$0.03(-0.37%)
At close: 4:00 PM EST
$9.60
-$0.03(-0.37%)
Day’s Range― - ―
52-Week Range$4.61 - $11.04
Previous CloseN/A
Volume2.40K
Average Volume (3M)169.38K
Market Cap
$182.42M
Enterprise Value$240.74M
Total Cash (Recent Filing)$955.00K
Total Debt (Recent Filing)$24.69M
Price to Earnings (P/E)35.7
Beta1.77
Next Earnings
Mar 18, 2026EPS Estimate
0.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.11
Shares Outstanding20,336,184
10 Day Avg. Volume113,747
30 Day Avg. Volume169,384
Financial Highlights & Ratios
PEG Ratio0.46
Price to Book (P/B)3.12
Price to Sales (P/S)1.33
P/FCF Ratio68.45
Enterprise Value/Market Cap1.32
Enterprise Value/Revenue1.71
Enterprise Value/Gross Profit3.08
Enterprise Value/Ebitda9.85
Forecast
1Y Price Target
$13.67Price Target Upside42.40% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)0.26
Revenue Forecast (FY)$143.88M
Bulls Say, Bears Say
Bulls Say
Financial PerformanceThe Company showed notable progress in gross margin improvement of 122 basis points Y/Y and AEBITDA margin improvement of 282 basis points Y/Y.
Operating Cash FlowOperating cash flow was $20.5M in 2024, an 82% increase Y/Y.
Bears Say
EarningsEPS of $0.04 was below our estimate and consensus of $0.08 and $0.09, respectively.
RevenueRevenue came in below our forecast and consensus due to delays in onboarding new wound care initiatives as the Company looks to improve referral processes with newer partners.
InfuSystem Holdings News
INFU FAQ
What was InfuSystem Holdings, Inc.’s price range in the past 12 months?
InfuSystem Holdings, Inc. lowest stock price was $4.61 and its highest was $11.04 in the past 12 months.
What is InfuSystem Holdings, Inc.’s market cap?
InfuSystem Holdings, Inc.’s market cap is $182.42M.
When is InfuSystem Holdings, Inc.’s upcoming earnings report date?
InfuSystem Holdings, Inc.’s upcoming earnings report date is Mar 18, 2026 which is in 103 days.
How were InfuSystem Holdings, Inc.’s earnings last quarter?
InfuSystem Holdings, Inc. released its earnings results on Nov 04, 2025. The company reported $0.11 earnings per share for the quarter, beating the consensus estimate of $0.08 by $0.03.
Is InfuSystem Holdings, Inc. overvalued?
According to Wall Street analysts InfuSystem Holdings, Inc.’s price is currently Undervalued.
Does InfuSystem Holdings, Inc. pay dividends?
InfuSystem Holdings, Inc. does not currently pay dividends.
What is InfuSystem Holdings, Inc.’s EPS estimate?
InfuSystem Holdings, Inc.’s EPS estimate is 0.07.
How many shares outstanding does InfuSystem Holdings, Inc. have?
InfuSystem Holdings, Inc. has 20,336,184 shares outstanding.
What happened to InfuSystem Holdings, Inc.’s price movement after its last earnings report?
InfuSystem Holdings, Inc. reported an EPS of $0.11 in its last earnings report, beating expectations of $0.08. Following the earnings report the stock price went down -9.038%.
Which hedge fund is a major shareholder of InfuSystem Holdings, Inc.?
Currently, no hedge funds are holding shares in INFU
InfuSystem Holdings Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$13.67 (42.40% Upside)
$13.67 (42.40% Upside)
Blogger Sentiment
Bullish
INFU Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 10.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.5%
Last 30 Days ▲ 3.5%
Last 30 Days ▲ 3.5%
Technicals
SMA
Positive
20 days / 200 days
Momentum
5.06%
12-Months-Change
Fundamentals
Return on Equity
9.95%
Trailing 12-Months
Asset Growth
-6.10%
Trailing 12-Months
Company Description
InfuSystem Holdings, Inc.
InfuSystem Holdings, Inc. is a leading provider of infusion therapy services and products in the United States, serving the healthcare sector with a focus on oncology, pain management, and other chronic conditions. The company specializes in the rental and sale of infusion pumps and related supplies, offering both durable medical equipment and comprehensive patient management services. InfuSystem operates through two primary segments: the Infusion Services segment, which provides outpatient infusion therapy services, and the Product Sales segment, which offers a range of infusion devices and supplies.
INFU Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a balanced view, with strong financial performance and strategic initiatives in Oncology and Wound Care. However, the decline in biomedical services revenue and Device Solutions offset some of the positive growth metrics. The company's focus on profitability and operational efficiency is evident, but challenges remain.View all INFU earnings summariesINFU Stock 12 Month Forecast
Average Price Target
$13.67
▲(42.40% Upside)
Technical Analysis
Orasure Technologies
―
Utah Medical Products
―
REPRO-MED Systems
―
Sanara MedTech
―
Sharps Technology, Inc.
―
Ownership Overview
10.12% Insiders
16.00% Mutual Funds
22.92% Other Institutional Investors
44.68% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---